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Background: Natural antioxidant products are increasingly being used to treat various pathological liver conditions
considering the role of oxidative stress in their pathogenesis. Rosemary essential oil has already being used as a
preservative in food industry due to its antioxidant and antimicrobial activities, but it was shown to possess
additional health benefits. The aim of our study was to evaluate the protective effect of rosemary essential oil on
carbon tetrachloride - induced liver injury in rats and to explore whether its mechanism of action is associated with
modulation of hepatic oxidative status.
Methods: Chemical composition of isolated rosemary essential oil was determined by gas chromatography and
mass spectrometry. Antioxidant activity was determined in vitro using DPPH assay. Activities of enzyme markers of
hepatocellular damage in serum and antioxidant enzymes in the liver homogenates were measured using the
kinetic spectrophotometric methods.
Results: In this research, we identified 29 chemical compounds of the studied rosemary essential oil, and the main
constituents were 1,8-cineole (43.77%), camphor (12.53%), and α-pinene (11.51%). Investigated essential oil was
found to exert hepatoprotective effects in the doses of 5 mg/kg and 10 mg/kg by diminishing AST and ALT
activities up to 2-fold in serum of rats with carbon tetrachloride - induced acute liver damage. Rosemary essential
oil prevented carbon tetrachloride - induced increase of lipid peroxidation in liver homogenates. Furthermore,
pre-treatment with studied essential oil during 7 days significantly reversed the activities of antioxidant enzymes
catalase, peroxidase, glutathione peroxidase and glutathione reductase in liver homogenates, especially in the dose
of 10 mg/kg.
Conclusions: Our results demonstrate that rosemary essential oil, beside exhibiting free radical scavenging activity
determined by DPPH assay, mediates its hepatoprotective effects also through activation of physiological defense
mechanisms.
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The liver has a central role in the metabolism, transport
and clearance of xenobiotics, and is therefore highly suscep-
tible to chemical-induced toxicity. In the Western world,
drug‐induced liver injury is a major health care problem
and accounts for the majority of acute liver failure cases
[1]. It is considered to be idiosyncratic and in addition to* Correspondence: nebojsa.pavlovic@gmail.com
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susceptibility of individuals to chemical-induced liver
injury. The pathophysiological mechanisms of chemical-
induced hepatotoxicity are not yet fully understood, but
are mostly associated with the metabolic conversion of
xenobiotics into reactive oxygen species (ROS), which
induce oxidative stress and damage the cellular macro-
molecules [2]. Oxidative stress, as the imbalance between
endogenous generation of ROS and activity of antioxidant
systems, has recently been recognized as a key factor inl Ltd. This is an Open Access article distributed under the terms of the Creative
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of liver diseases, such as subclinical hepatitis without jaun-
dice, inflammatory necrotic hepatitis, liver cirrhosis and
hepatocellular carcinoma [3,4]. Better understanding the
role of oxidative stress in these liver disorders may lead to
the appropriate use of antioxidants as a therapeutic ap-
proach for liver diseases. Natural antioxidant products,
especially phytochemicals, have gained popularity world-
wide due to their efficacy and safety. They are increasingly
being used to treat various pathological liver conditions
and nearly half of the agents used in liver therapy today
are either natural products or their derivatives [5].
Rosemary (Rosmarinus officinalis L., Lamiaceae) is a woody
perennial herb, native to the Mediterranean region, but is
now cultivated all over the world as an ornamental and
aromatic plant. The leaves of rosemary are commonly
used for flavoring foods as a condiment, but this plant has
also been widely used for different medicinal purposes. In
traditional medicine, rosemary has been used as a stimu-
lant and mild analgesic, and it has been considered as one
of the most effective herbs for treating headaches, poor
circulation, inflammatory diseases, and physical and men-
tal fatigue. Rosemary has also been used empirically as a
choleretic and hepatoprotective agent in folk medicine
[6,7]. Most pharmacological effects of rosemary are the
consequence of high antioxidant activity of its main chem-
ical constituents, which include carnosol, carnosic acid,
ursolic acid, rosmarinic acid, and caffeic acid. The potent
antioxidant properties of rosemary have been mainly at-
tributed to its major diterpenes, carnosol and carnosic
acid, as well as to the essential oil components [8].
Recently, the essential oils and their active compounds
have been of great interest due to their pharmacological
properties. Essential oils are complex mixtures of volatile
compounds with strong odor that are synthesized in sev-
eral plant organs and exert diverse ecological functions
[9]. Due to their biological activities, the essential oils
have been reported to be useful in food preservation, fra-
grance industry and aromatherapy [10]. Rosemary essen-
tial oil (REO) is a colorless or pale yellow liquid, with
characteristic odor of the plant, and consists mostly of
monoterpenes such as 1,8-cineole, camphor and α-pinene
[6]. Due to its antioxidant and antimicrobial activity
[11,12], REO is capable to extend the shelf-life of food
products and maintain their quality during storage. There-
fore, it has already being used as a biopreservative in food
industry [13].
In addition to acting as an antioxidant agent, the es-
sential oil isolated from rosemary possesses various
health benefits and therapeutic effects. According to the
recommendation of European Medicines Agency (EMA)
from 2010, REO can be used for treating dyspepsia and
mild spasmodic disorders of the gastrointestinal tract, as
well as an adjuvant in the relief of minor muscular andarticular pain and in minor peripheral circulatory disor-
ders [14]. Besides, the experiments conducted with REO
have demonstrated its several notable pharmacological
effects, such as anti-inflammatory and antinociceptive
[15], antidepressant [16], cognition-enhancing [17], DNA-
protective [18] and anticancer effects [19], among others.
The hepatoprotective effects of rosemary have been ob-
served in different experimental models of liver injury.
The rosemary methanol extract has been effective against
carbon tetrachloride (CCl4)-induced acute liver damage
[20], and the rosemary water extract could prevent
azathioprine-induced acute liver injury in rats [21]. The
methanol extract of rosemary could also prevent hepato-
toxicity in both prevention and reversion experimental
models of liver cirrhosis induced by CCl4 [22]. To the best
of our knowledge, the potential hepatoprotective activity
of essential oil from rosemary, which contains monoter-
penes as its main active compounds, has not been previ-
ously tested in vivo. The aim of the present study was to
examine the chemical composition of essential oil isolated
from the aerial parts of Rosmarinus officinalis by GC/MS,
to evaluate the protective effect of the obtained essential
oil on CCl4-induced liver injury in rats and to explore
whether its mechanism of action is associated with modu-
lation of hepatic oxidative status.
Methods
Plant material and chemicals
Aerial parts of cultivated plants of rosemary were obtained
from the Institute for Studies on Medicinal Plants, Dr Josif
Pančić, Belgrade, in 2010. A voucher specimen of the plant
(Rosmarinus officinalis L. 1753 subsp. officinalis No 2–1746,
det.: Goran Anačkov) was confirmed and deposited in the
Herbarium of the Department of Biology and Ecology,
Faculty of Sciences, University of Novi Sad. The essential
oil, used in our experiments, was isolated from the ob-
tained plant material.
Carbon tetrachloride was obtained fromMerck (Darmstadt,
Germany). All chemicals for biochemical assays were pur-
chased from Sigma-Aldrich (St Louis, MO, USA), unless
otherwise stated.
Isolation and qualitative and quantitative analysis of
essential oil
The essential oil was isolated from the aerial parts of rose-
mary by hydrodistillation, according to the procedure of
the European Pharmacopoeia 4 [23]. n-Hexane was used
as a collecting solvent, which was afterward removed
under vacuum from the obatined essential oil.
The identification and quantification of chemical con-
stituents of the essential oil were carried out by gas chro-
matography coupled with flame ionization detection (GC/
FID) and mass spectrometric detection (GC/MS). GC/FID
analysis was performed using a Hewlett-Packard HP 5890
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and a split/splitless injection system. The capillary column
used in this study was HP-5 (25 m × 0.32 mm; film thick-
ness of 0.52 μm), coupled to the flame ionization detector
(FID). The injector and detector temperatures were set at
250°C and 300°C, respectively, and the column temperature
was programmed from 40 to 260°C at a rate of 4°C/min.
The flow rate of hydrogen as a carrier gas was 1 ml/min.
A sample of 1% solution of the oil in ethanol (1 μl) was
injected in split mode (split ratio, 1:30). GC/MS analysis
was carried out using a Hewlett-Packard HP G1800C
series II GCD system under the same analytical conditions
as in GC/FID. The column HP-5MS (30 m × 0.25 mm;
film thickness 0.25 μm) and helium as a carrier gas were
used in this analysis. The system was operated in electron
ionization (EI) mode at 70 eV, in the mass (m/z) range
40–450 Da.
Identification of essential oil constituents was performed
by comparison of obtained mass spectra and retention
indexes with those from NIST mass spectra library
(IBM-AT, version 2, 1990) and literature data. The quanti-
tative analysis provided the percentage composition of the
essential oil components, calculated by FID peak area
normalization method.
Evaluation of in vitro antioxidant activity and total phenol
content of essential oil
Antioxidant activity of the rosemary essential oil (REO)
was evaluated as free radical scavenging capacity (RSC).
The ability of REO to donate an electron and scavenge
the stable 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical
was investigated [24]. The essential oil and methanol so-
lution of α-tocopherol, as a positive control, were mixed
with DPPH solution and after 60 minutes, remaining
amount of the purple-colored DPPH radical was mea-
sured spectrophotometrically at 515 nm. Free radical
scavenging capacity was calculated as follows: RSC =
100–100 * Asample/Ablank, where Ablank is the absorbance
of diluted DPPH solution and Asample is the absorbance
of the essential oil/reference. All the assays were carried
out in triplicate and the average values were considered.
The IC50 value, which represents the concentrations of
the sample required to cause 50% inhibition of DPPH
radical, was estimated by linear regression analysis from
the obtained RSC values and was expressed in μl of es-
sential oil per ml.
Phenolic content of REO was assayed using the Folin-
Ciocalteu reagent [25]. The essential oil was mixed with
Folin-Ciocalteu reagent and sodium carbonate solution
in test tube. After being vortexed and incubated in dark
for 2 h, absorbance was measured at 740 nm. Estimation
of total phenol content was carried out in triplicate and
the result was expressed as mg of gallic acid equivalents
(GAE) per liter.Animals and treatment
The experiment was performed on 7–8 week old albino
Wistar rats of both sexes, weighing 200–250 g, obtained
from Military Medical Academy, Belgrade. The rats were
housed in standard laboratory cages, under a 12 h light–
dark cycle, at a constant ambient temperature (23°C)
and humidity (30-50%), and were allowed to adapt for
4 weeks before the experiments were started. The ani-
mals were maintained on standard pellet diet (LM2,
Veterinary Institute, Subotica, Serbia) and allowed access
to tap water ad libitum. Animal care and all experimen-
tal procedures were conducted in accordance with the
Guide for the Care and Use of Laboratory Animals edi-
ted by Commission of Life Sciences, National Research
Council (USA). The study was approved by the Ethical
Committee of the University of Novi Sad.
To evaluate the effect of REO on CCl4-induced liver
injury, the animals were randomly divided into six experi-
mental groups, each containing six individuals, and treated
as follows:
 Con S: Control group, saline 1 ml/kg i.p.
 Con CCl4: saline 1 ml/kg i.p. + a single CCl4 dose
1 ml/kg i.p.
 REO5: rosemary essential oil 5 mg/kg p.o.
 REO5 + CCl4: rosemary essential oil 5 mg/kg p.o. + a
single CCl4 dose 1 ml/kg i.p.
 REO10: rosemary essential oil 10 mg/kg p.o.
 REO10 + CCl4: rosemary essential oil 10 mg/kg p.o.
+ a single CCl4 dose 1 ml/kg i.p.
REO was applied by per os gavage, previously suspended
in saline. The variability in the volume of administered
doses was managed by adjusting the concentration to en-
sure a constant volume (1 ml/kg). REO and saline were
administered every day for seven days. On the 7th day, 1 h
after the last dose of REO or saline, animals were treated
intraperitoneally with CCl4 dissolved in olive oil (1:1,
1 ml/kg). After 24 h, rats were anesthetized with urethane
(0.75 mg/kg) and sacrificed by cardiopunction, and the
samples of blood and liver were taken [26]. The obtained
serum was used for determination of standard biochem-
ical parameters. Liver homogenates were prepared from
1 g of liver tissues which were homogenized in a Potter
homogenizer with Tris–HCl sucrose buffered solution in a
ratio 1:3 (w/v) at 4°C. The parameters of oxidative stress
were analyzed in obtained liver homogenates.
Serum biochemical parameters determination
Total cholesterol and triglycerides levels as biochemical
parameters related to lipid status, bilirubin level as a marker
of the liver excretory function, activities of enzyme markers
of hepatocellular damage, including alanine aminotransfer-
ase (ALT) and aspartate aminotransferase (AST), and the
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of renal excretory function were determined in serum. All
analyses were performed in triplicate for every sample on
the Olympus AU 400 autoanalyzer (Hamburg, Germany)
by using commercially available kits based on the well-
established spectrophotometric methods, according to the
manuals supplied.
Triglycerides and cholesterol were quantitated by en-
zymatic colorimetric methods. Glycerol phosphate oxidase-
peroxidase (GPO-POD) and cholesterol oxidase-peroxidase
(CHOD-POD) methods were applied for determination of
triglycerides and cholesterol, respectively. Total and direct
bilirubin concentrations in serum were estimated by col-
orimetric DPD method, based on the reaction between
bilirubin and 2,5-dichlorophenyldiazonium salt to produce
an azobilirubin complex. AST and ALT activities were
measured by standard IFCC methods. Serum level of cre-
atinine was measured by modified Jaffe’s method, and de-
terminations of urea and uric acid levels were performed
using glutamate dehydrogenase (GLDH-UV) and uricase-
peroxidase kinetic methods, respectively.
Determination of oxidative status in the liver
Oxidative status in the liver was estimated by measuring
the levels of lipid peroxidation (LPx) and reduced glutathi-
one (GSH), and the activities of antioxidant enzymes,
including catalase (CAT), peroxidase (Px), glutathione
peroxidase (GPx), and glutathione reductase (GR) in
liver homogenates, using the spectrophotometric methods.
All measurements were performed in triplicate for every
sample.
The intensity of LPx was estimated by measuring the
amount of malondialdehyde, a terminal product of lipid
breakdown due to peroxidation damage, using the method
of Buege and Aust [27]. The content of GSH was deter-
mined by the reaction with 5,5′-dithiobis (2-nitrobenzoic
acid), according to the method of Kapetanović and Mieyal
[28]. CAT activity was determined by the method based
on monitoring the H2O2 decomposition rate at 240 nm
[29], and Px activity by using guaiacol as the enzyme’s sub-
strate [30]. The activities of GPx and GR were determined
following the methods of Beutler [31] and Goldberg and
Spooner [32], respectively. These tests were based on the
measuring the decrease in absorbance caused by the oxi-
dation of NADPH at 340 nm (UV assay).
Statistical analysis
Data are expressed as mean ± standard error of the mean
(SEM). The intergroup variation between various groups
was measured by one-way analysis of variance (ANOVA)
followed by Tukey’s multiple comparison test. Results
were considered statistically significant when p < 0.05. Data
were analyzed using SPSS software, version 19 (IBM SPSS,
Chicago, IL, USA).Results
REO chemical composition
The essential oil distilled from the rosemary had a pale
yellow color and a strong odor, and the obtained yield of
the essential oil was 1.03% (v/w in dry matter). The total
number of identified chemical constituents was 29, repre-
senting 99.87% of the total oil content. The percentage
composition of REO is presented in Table 1.
The essential oil contains a complex mixture of 95.10%
of monoterpenes and 4.77% of sesquiterpenes. It was
found to be composed mainly of oxygenated monoter-
penes (63.88%), followed by monoterpene hydrocarbons
(31.22%) and sesquiterpene hydrocarbons (4.77%). The
major compounds that were identified and quantitated by
GC-FID and GC-MS were 1,8-cineole (43.77%), camphor
(12.53%), α-pinene (11.51%), β-pinene (8.16%), camphene
(4.55%), and β-caryophyllene (3.93%) (Additional files 1
and 2).
In vitro antioxidant activity of REO
The antioxidant activity of REO was evaluated by the
DPPH free radical scavenging test and the result was pre-
sented by IC50 value, defined as the concentration of the
antioxidant needed to scavenge 50% of DPPH present in
the test solution. The results demonstrated that the essen-
tial oil had a strong radical scavenging activity with an
IC50 value of 77.6 μl/ml. A comparison was made with α-
tocopherol (vitamin E), well-known potent antioxidant
and free radical scavenger, which exhibited an IC50 value
of 25.3 μg/ml. According to that, 1 μg of α-tocopherol was
found to be equivalent to 3.1 μl of the studied REO.
Antioxidant activity of rosemary essential oils was re-
ported to be derived partly from the presence of phen-
olic groups [33]. We measured total phenol content in
order to determine if this class of chemical compounds
contributes to free radical scavenging capacity of REO,
besides monoterpenes. Total phenol content of investi-
gated REO was measured using the Folin-Ciocalteu
method and the relatively small amount of total phenols
of 153.35 mg GAE/l was determined.
Effects of REO on CCl4-induced serum biochemical
parameters
In our study, we investigated the concentrations of tri-
glycerides and cholesterol in serum in order to evaluate
the effect of REO on metabolic function of the liver.
CCl4 induced a slight decrease in triglycerides and choles-
terol levels which was partially recovered after administra-
tion of REO in a dose of 5 mg/kg. The intake of REO
alone did not affect significantly the metabolic function of
the liver (Table 2).
The treatment of animals with CCl4 induced statisti-
caly significant increase in both total and direct bilirubin
levels in serum. Increased concentration of bilirubin in
Table 1 Chemical composition of the rosemary
essential oil




Tricyclene 12.640 6.82 0.579 0.23
α-Thujene 12.777 7.00 0.585 0.13
α-Pinene 13.100 7.19 0.600 11.51
Camphene 13.737 7.62 0.629 4.55
Sabinene 14.697 8.47 0.673 0.05
β-Pinene 14.887 8.50 0.681 8.16
β-Myrcene 15.292 9.04 0.700 0.99
α-Phellandrene 15.955 9.43 0.730 0.19
δ3-Carene 16.212 9.62 0.742 0.13
α-Terpinene 16.456 9.85 0.753 0.14
p-Cymene 16.782 10.13 0.768 1.23
Limonene 16.970 10.25 0.777 2.80
γ-Terpinene 18.178 11.30 0.832 0.92
α-Terpinolene 19.416 12.31 0.889 0.19
Oxygenated monoterpenes 63.88
1,8-cineole 17.124 10.43 0.784 43.77
Linalool 19.746 12.82 0.904 0.46
Camphor 21.845 14.30 1.000 12.53
Isoborneol 22.318 14.71 1.022 0.53
Borneol 22.655 15.05 1.037 2.97
Terpinen-4-ol 23.059 15.44 1.056 0.56
α-Terpineol 23.548 15.93 1.078 1.53
γ-Terpineol 23.802 16.17 1.090 0.40
Bornyl acetate 27.185 19.14 1.244 1.13
Sesquiterpene hydrocarbons 4.77
α-Copaene 30.598 22.03 1.401 0.12
Longifolene 31.866 22.93 1.459 0.18
β-Caryophyllene 32.240 23.41 1.476 3.93
α-Humulene 33.406 24.45 1.529 0.36
Germacrene D 34.029 25.18 1.558 0.08
δ-Cadinene 35.528 26.59 1.626 0.10
Total identified 99.87
Number of compunds identified 29
aRT-FID - retention time in GC/FID system; bRT-MS - retention time in GC/MS
system; cRRT - relative retention time with respect to camphor.
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This effect was additionally exacerbated after the co-
treatment with REO in the dose of 10 mg/kg. To confirm
that CCl4-induced liver injury had occurred, AST and
ALT activities were measured in serum. AST and ALT ac-
tivities were increased 25- and 19-fold respectively in Con
CCl4 group compared to saline-treated group, and this isknown to occurs mainly due to leakage of these enzymes
from damaged hepatocytes into the bloodstream. The
treatment of animals with REO attenuated these parame-
ters of hepatotoxicity, especially in the group treated with
REO in a dose of 10 mg/kg in which AST activity was sig-
nificantly decreased compared to CCl4-treated group.
Serum concentrations of urea, creatinine and uric acid,
as biomarkers of renal function, were also examined.
These biochemical parameters were increased in CCl4-
treated group, indicating its nephrotoxicity, but were sig-
nificantly restored after REO administration.
Effects of REO on CCl4-induced oxidative stress
In order to analyze the antioxidative potential of REO to
prevent the CCl4-induced biochemical changes in the
liver of rats, we measured the malondialdehyde (MDA)
and glutathione (GSH) levels and activities of catalase
(CAT), peroxidase (Px), glutathione peroxidase (GPx),
and glutathione reductase (GR) as biomarkers of REO
effects.
The single dose of CCl4 induced 3.5-fold increase in
MDA level compared to the negative control group of
rats 24 h after the administration, suggesting the oxida-
tive damage of cell membranes. This was accompanied
by the significant reduction of GSH concentration (0.73 ±
0.05 nmol vs. 1.71 ± 0.17 nmol GSH/mg of proteins in
control group), and activities of all examined antioxidant
enzymes, except GPx, showing increased activity in the
liver homogenates (Figure 1).
Our results showed that daily administration of REO
could partially normalize altered biochemical parameters
in the experimental model of acute liver injury. Pre-
treatment with REO in both doses during 7 days signifi-
cantly reversed the oxidative stress-related biochemical
parameters in liver homogenates, especially in the dose
of 10 mg/kg in which REO reversed these parameters
near to the values of negative control group. Besides, ad-
ministration of REO alone also modified significantly
most of the studied oxidative stress biomarkers and im-
proved oxidative status of the liver.
Discussion
In this research, we determined the chemical composition
of the studied REO, its free radical scavenging activity, and
its potential to ameliorate liver injury induced by pro-
oxidant agent CCl4. Earlier studies regarding the chemical
composition of essential oils isolated from rosemary indi-
cate the existence of three main chemotypes. The main
component of the Tunisian, Turkish, Moroccan and Ital-
ian oils is 1,8-cineole with usually over 40%, whereas most
Spanish, French and Greek oils have 1,8-cineole, α-pinene
and camphor with approximately equal ratios (20-30%).
The myrcene-rich rosemary oil chemotype has been re-
ported in South America [13]. The main constituents in
Table 2 Effects of the rosemary essential oil on biochemical parameters in serum
Con S Con CCl4 REO5 REO5 + CCl4 REO10 REO10 + CCl4
Triglycerides (mmol/l) 0.81 ± 0.08 0.52 ± 0.04 0.79 ± 0.06 0.63 ± 0.09 1.03 ± 0.10# 0.42 ± 0.03*
Cholesterol (mmol/l) 1.56 ± 0.08 1.38 ± 0.08 1.39 ± 0.03 1.54 ± 0.06 1.68 ± 0.06 1.31 ± 0.13
Total bilirubin (μmol/l) 2.05 ± 0.15 4.02 ± 0.35* 2.24 ± 0.06# 3.94 ± 0.35* 2.55 ± 0.07# 6.22 ± 0.50*,#
Direct bilirubin (μmol/l) 0.35 ± 0.03 1.32 ± 0.24* 0.38 ± 0.05# 1.16 ± 0.15* 0.55 ± 0.02# 2.81 ± 0.29*,#
AST (U/l) 125.3 ± 4.2 3185.0 ± 477.9* 130.2 ± 6.2# 2701.7 ± 583.0* 143.7 ± 7.9# 1648.6 ± 104.4*,#
ALT (U/l) 49.7 ± 1.7 966.8 ± 244.4* 63.8 ± 4.3# 595.4 ± 143.7 65.7 ± 2.1# 893.5 ± 200.8*
Urea (mmol/l) 7.28 ± 0.25 7.72 ± 0.17 7.65 ± 0.08 7.98 ± 0.29 7.45 ± 0.24 6.33 ± 0.29#
Creatinine (μmol/l) 46.0 ± 1.18 53.2 ± 0.70* 44.2 ± 1.14# 51.5 ± 1.59* 50.3 ± 0.42 47.7 ± 0.99#
Uric acid (μmol/l) 62.0 ± 1.73 104.0 ± 12.02* 53.0 ± 2.86# 74.3 ± 5.86# 60.7 ± 3.69# 79.2 ± 6.65
All values are expressed as mean ± SEM. (*) significantly different from Con S group; (#) significantly different from Con CCl4 group; p < 0.05.
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1,8-cineole (43.77%), camphor (12.53%), and α-pinene
(11.51%). Therefore, REO from our study can be catego-
rized in the Morocco/Tunisian type. It should be noted
that significant variations in the chemical composition of
rosemary essential oils have been reported. Several factors
were found to influence the composition of essential oils,
including the geographic origin, part of the plant, season
of harvesting, hence the phenological stage of the plant,
and also the essential oil isolation method [9]. All effects
of REO should be therefore carefully examined, consider-
ing the chemical composition of the investigated oil.
We evaluated in vitro antioxidant activity of REO and
demonstrated a relatively high DPPH radical scavengingFigure 1 Levels of lipid peroxidation (LPx), glutathione (GSH), catalas
glutathione reductase (GR) in liver homogenates. (*) significantly differe
group; p < 0.05.capacity with IC50 value of 77.6 μl/ml. Our results are in
agreement with previous data reported on the antioxi-
dant activity of essential oils of rosemary. Free radical
scavenging activity, and chemical composition of the oil
we investigated as well, were similar to the essential oil
obtained from the rosemary cultivated in South-Western
Tunisia, as demonstrated in the study of Kadri et al.
[10]. IC50 values generally vary considerably among stud-
ies, which can be explained by different chemical com-
positions of rosemary essential oils. The chemotype of
rosemary myrcene-rich essential oils has been recently
shown to have the highest antioxidant activity [13]. In
the study aimed to evaluate and compare the free radical
scavenging properties of REO with three of its componentse (CAT), peroxidase (Px), glutathione peroxidase (GPx), and
nt from Con S group; (#) significantly different from Con CCl4
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IC50 value and hence greater antioxidant activity than all
its components, and than the synthetic antioxidant butyl-
ated hydroxytoluene (BHT) as well [34]. This means that
in addition to the major compounds, minor components
may also contribute significantly to the activity of REO. In
another study, the essential oils from five plants that are
widely used in a Mediterranean diet (oregano, thyme,
clove, sage, and rosemary) were tested for their antioxi-
dant properties, using six in vitro methods, and the results
showed that REO had the highest iron-chelating ability.
Besides, REO exhibited total phenol content of 225 mg
GAE/l [33], which can be considered as a low source of
phenols in comparison to other investigated essential oils,
and is relatively similar to the results of our study. This
means that oxygenated monoterpenes, probably monoter-
penoid ketones with established antioxidant properties,
may have the greatest contribution to the antioxidant cap-
acity of REO.
The hepatoprotective effects of REO were investigated
by measuring ALT and AST activities, as enzyme markers
of hepatocellular damage, in serum. In our study, we also
evaluated the effects of REO on metabolic and excretory
functions of the liver, and renal excretory function as well.
It is well known that CCl4, as a highly toxic and pro-
oxidant agent, produce the damage of hepatocytes to
cause large increases in ALT and AST activities and eleva-
tion in bilirubin content in serum. REO was found to exert
hepatoprotective effects in both doses by diminishing
AST and ALT activities in serum, as the most specific
markers of liver injury, compared to CCl4-treated group.
Similarly, results of the study by Sotelo-Félix et al. [20]
and Gutiérrez et al. [22] showed that methanolic extract
of rosemary in a dose of 200 mg/kg could restore the
elevated ALT activity in both acute liver damage and
liver cirrhosis experimental models. Interestingly, co-
administration of REO in the dose of 10 mg/kg with CCl4
resulted in exacerbation of bilirubin values in serum indi-
cating impaired excretory function of the liver. On the
contrary, REO in the dose of 5 mg/kg did not exert that
effect. This is in agreement with previous findings that
many monoterpenes do not exhibit dose-dependent ef-
fects and that it is necessary to find the most appropriate
dose range that shows effectiveness [35]. Among numer-
ous terpenoids, camphor, a bicyclic monoterpene which is
present in our REO in a relatively high amount (12.53%),
is a potentially toxic compound and a small amount can
cause poisoning in children. Camphor is neurotoxic, and
is also toxic to the liver, but the mechanisms are still to be
elucidated. It was demonstrated that camphor is oxidized
to 5-exo-hydroxyfenchone derivatives in human liver mi-
crosomes, and that might contribute to hepatic excretory
impairment after administration of REO in the dose of
10 mg/kg [36,37]. Monoterpene α-pinene might also exerttoxic effects in high doses. It was demonstrated that α-
pinene exhibited cytotoxicity on cultured human blood
cells when applied in high concentration (200 mg/l) [38],
and this compound was also confirmed to be porphyro-
genic and therefore especially hazardous to those with de-
fects in hepatic heme synthesis [39].
In addition to hepatoprotective effects, as indicated by
AST and ALT values, the nephroprotective potential of
REO was also observed in our study. The intake of REO
in a dose of 10 mg/kg produced statisticaly significant
diminution in urea and creatinine levels compared to Con
CCl4 group. These results suggest the ability of REO to re-
store impaired renal excretory function. This is in accord-
ance with results of the study by Sakr and Lamfon [40],
indicating that water extract of rosemary could reduce the
levels of urea and creatinine in serum of rats, when com-
pared to CCl4-treated group of animals.
Considering the role of reactive oxygen species (ROS)
in chemical-induced liver injury and various liver dis-
eases, we used the model of acute liver damage induced
by CCl4 since the oxidative stress is the main mechan-
ism involved in hepatotoxicity of CCl4. This compound
is metabolized via reductive dehalogenation involving
cytochrome P450, which is accompanied by formation of
the radicals CCl3
• and Cl3COO
• causing the peroxidation
of membrane lipids. MDA is one of the well-known sec-
ondary products of lipid peroxidation, and it was used as
an indicator of cell membrane injury. As demonstrated
in Figure 1, REO showed ability to prevent CCl4-induced
increase in MDA level, which suggests that REO can pre-
serve cellular integrity and this may be the consequence
of free radical scavenging activity determined by DPPH
assay. Previous findings showed that methanolic extracts
of rosemary, although different in chemical composition
from REO, could also inhibit lipid peroxidation in the liver
of CCl4-treated rats [20]. In addition to antilipoperoxidant
activity, REO was also found to efficiently reduce the
levels of hydrogen peroxide (H2O2)- and 2,3-dimethoxy-
1,4-naphthoquinone (DMNQ)-induced oxidative damage
of DNA in isolated rat hepatocytes, and testicular cells as
well [18,41].
The effects of ROS are balanced by antioxidant defense
system involving a variety of enzymatic and non-enzymatic
mechanisms. GSH is the main non-enzymatic endogenous
antioxidant in the cells. Antioxidant enzymes Px, GPx and
CAT catalyze the reduction of peroxides to alcohols or
water. GR reduces glutathione disulfide (GSSG), generated
during the reduction of peroxides, to the sulfhydryl form
of glutathione (GSH) [4]. In our study, we investigated
also the effects of REO on antioxidant defense system of
hepatocytes, and our results showed that administration
of CCl4 induced the significant depletion of GSH level
in liver homogenates. In addition to serving as a cofactor
for several antioxidant enzymes, GSH can interact directly
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in detoxifying CCl4 metabolites. Depletion of GSH was ac-
companied by a significant reduction of CAT, Px and GR
activities, which can be explained by their inactivation in-
duced by excessive ROS production. Interestingly, activity
of the antioxidant enzyme GPx was increased in the liver
after administration of CCl4. Similar results were obtained
in the study of Hsiao et al. [42], where it was demon-
strated that CCl4 induced increase of GPx activity and re-
duction of CAT activity. These enzymes are activated in
the defense against oxidative cell injury. CAT has an im-
portant role in the elimination of ROS derived from the
redox process of xenobiotics in the liver, and it was sug-
gested that CAT is easily inactivated by lipid peroxides
[43]. On the other hand, under oxidative stress conditions,
GPx can be upregulated as the adaptive response of the
hepatocytes to oxidative damage, and GSH is then largely
consumed, which is in accordance with results of our
study. The essential oil isolated from rosemary signifi-
cantly reversed all these biochemical parameters referring
to oxidative status of the liver, especially in the dose of
10 mg/kg.
Hepatoprotective activity of investigated essential oil
isolated from rosemary can be attributed to 1,8-cineole,
as its major compound. This monoterpene was reported
to have various pharmacological effects, such as smooth
muscle relaxant, anti-inflammatory, antioxidant and
hypotensive. In an in vivo murine model of septic shock
syndrome induced by D-galactosamine/lipopolysacchar-
ide that is characterized by early apoptosis and subse-
quent lysis of hepatocytes, 1,8-cineole not only
suppressed increase in liver weight and the elevation in
serum transaminase activity, but also prevented the ne-
crosis and haemorrhage to a greater extent than dexa-
methasone. Hepatoprotection was suggested to be
associated with a reduction in TNF-α serum concentra-
tion [44]. In rats treated with the environmental contam-
inant 2,3,7,8-tetracholorodibenzo-p-dioxin (TCDD) for
30 days, activities of antioxidant enzymes GPx and CAT,
and GSH levels in liver were significantly decreased,
whereas MDA levels were significantly increased com-
pared to the non-treated group. When given together
with TCDD, 1,8-cineole increased GPx, CAT, GSH
levels, while reducing MDA concentration close to the
level of the control group, suggesting activation of anti-
oxidant defense systems as one of the mechanisms of
hepatoprotection induced by 1,8-cineole [45]. Similarly,
it was found that 1,8-cineole treatment improved colonic
oxidative balance in rats with TNBS-induced colitis,
since it was able to reduce the myeloperoxidase activity,
a marker of polymorphonuclear leukocyte accumulation
and could restore the tissue levels of GSH as the major
intracellular antioxidant [46]. Besides 1,8-cineole, anti-
oxidant activity was determined also for α-pinene, abicyclic monoterpene that is present in the studied essen-
tial oil in our study in a relatively high amount (11.51%),
and this compound could contribute to hepatoprotective
activity of REO as well [38]. The contribution of various
compounds that are present in small amounts in the es-
sential oil could be also important for the effects on liver,
and their mechanisms of action are still to be elucidated.
Conclusions
In summary, the present results demonstrate that admin-
istration of REO, exhibiting free radical scavenging activity
determined by DPPH assay, exerts beneficial effects on
preventing CCl4-induced hepatotoxicity in rats by limiting
the extent of lipid peroxidation and hence cell membranes
injuries. Considering the significant impact on activities of
examined antioxidant enzymes, it is clear that REO medi-
ates its hepatoprotective effects not only through scaven-
ging of harmful free radicals, but also through activation
of physiological defense mechanisms. It should be empha-
sized that there have been considerable variations in the
chemical composition of essential oils obtained from rose-
mary, and for this reason, the use of REO in preventing
and/or treatment of various liver diseases requires the
identification of active ingredients and further investiga-
tions on their mechanisms of action.
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